Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

被引：892

作者：

Fearon, Kenneth C. H. ^{[1
]}

Glass, David J. ^{[2
]}

Guttridge, Denis C. ^{[3
]}

机构：

[1] Univ Edinburgh, Royal Infirm, Sch Clin Sci & Community Hlth, Edinburgh EH16 4SA, Midlothian, Scotland

[2] Novartis Inst Biomed Res, Cambridge, MA 02139 USA

[3] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA

来源：

CELL METABOLISM | 2012年 / 16卷 / 02期

关键词：

SKELETAL-MUSCLE ATROPHY; TUMOR-NECROSIS-FACTOR; ACUTE-PHASE RESPONSE; UBIQUITIN LIGASE ATROGIN1/MAFBX; ADIPOSE TRIGLYCERIDE LIPASE; PROTEOLYSIS INDUCING FACTOR; FOXO TRANSCRIPTION FACTORS; SYNTHASE KINASE 3-BETA; MESSENGER-RNA LEVELS; KAPPA-B ACTIVATION;

D O I：

10.1016/j.cmet.2012.06.011

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Cancer cachexia is characterized by a significant reduction in body weight resulting predominantly from loss of adipose tissue and skeletal muscle. Cachexia causes reduced cancer treatment tolerance and reduced quality and length of life, and remains an unmet medical need. Therapeutic progress has been impeded, in part, by the marked heterogeneity of mediators, signaling, and metabolic pathways both within and between model systems and the clinical syndrome. Recent progress in understanding conserved, molecular mechanisms of skeletal muscle atrophy/hypertrophy has provided a downstream platform for circumventing the variations and redundancy in upstream mediators and may ultimately translate into new targeted therapies.

引用

页码：153 / 166

页数：14

共 50 条

[41] Magnolol inhibits myotube atrophy induced by cancer cachexia through myostatin signaling pathway in vitro
Ge, Zhijuan
Liu, Dong
Shang, Yue
Li, Yi
Chen, Shu-zhen
JOURNAL OF NATURAL MEDICINES, 2020, 74 (04) : 741 - 749
[42] Decrease in malonyl-CoA and its background metabolic alterations in murine model of cancer cachexia
Celik, Alper
Kano, Yoshihiko
Tsujinaka, Shingo
Okada, Sinichirou
Takao, Koichi
Takagi, Masakazu
Chohnan, Shigeru
Soda, Kuniyasu
Kawakami, Masanobu
Konishi, Fumio
ONCOLOGY REPORTS, 2009, 21 (04) : 1105 - 1111
[43] Neural Mechanisms of Cancer Cachexia
Olson, Brennan
Diba, Parham
Korzun, Tetiana
Marks, Daniel L.
CANCERS, 2021, 13 (16)
[44] Protein breakdown in cancer cachexia
Sandri, Marco
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2016, 54 : 11 - 19
[45] Cancer-Associated Cachexia.: A Systemic Consequence of Cancer Progression.
Biswas, Anup K.
Acharyya, Swarnali
ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 2020, 4 : 391 - 411
[46] Role for Plant-Derived Antioxidants in Attenuating Cancer Cachexia
Li, Wenlan
Swiderski, Kristy
Murphy, Kate T.
Lynch, Gordon S.
ANTIOXIDANTS, 2022, 11 (02)
[47] Cancer cachexia-anorexia syndrome and skeletal muscle wasting
Jurdana, Mihaela
RADIOLOGY AND ONCOLOGY, 2009, 43 (02) : 65 - 75
[48] Revisiting Cancer Cachexia: Pathogenesis, Diagnosis, and Current Treatment Approaches
Baba, Mudasir Rashid
Buch, Sajad Ahmad
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021, 8 (05) : 508 - 518
[49] Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia
Melstrom, L. G.
Melstrom, K. A., Jr.
Ding, X.-Z.
Adrian, T. E.
HISTOLOGY AND HISTOPATHOLOGY, 2007, 22 (07) : 805 - 814
[50] Cancer Cell Signaling Pathways Targeted by Spice-Derived Nutraceuticals
Sung, Bokyung
Prasad, Sandeo
Yadav, Vivek R.
Aggarwal, Bharat B.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2012, 64 (02): : 173 - 197

← 1 2 3 4 5 →